This compound is primarily utilized in pharmaceutical research and development as a key intermediate in the synthesis of biologically active molecules. Its structure, featuring a difluoropiperidine core and a protected amine group, makes it valuable for designing drug candidates targeting central nervous system disorders. It is often employed in the preparation of compounds with potential therapeutic effects on conditions such as depression, anxiety, or neurodegenerative diseases. The tert-butyl carboxylate group provides stability during synthetic processes, while the difluoropiperidine moiety can enhance metabolic stability and bioavailability of the final drug molecule. Its application extends to medicinal chemistry, where it serves as a building block for creating novel compounds with optimized pharmacological properties.